Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
Selected ventures to receive grants and structured intellectual property support to strengthen protection and management of healthcare innovations
New regulation mandates stricter prescription monitoring, sales record maintenance, and enhanced compliance across the pharmaceutical supply chain
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
Net income more than doubled to 2.763 billion euros, while core earnings per share climbed 12.9 percent to 2.71 euros
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Subscribe To Our Newsletter & Stay Updated
